Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Urinary System Drugs>Diuretics Drugs>Trichlormethiazide
Trichlormethiazide
  • Trichlormethiazide

Trichlormethiazide NEW

Price $45
Package 500mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-04-27

Product Details

Product Name: Trichlormethiazide CAS No.: 133-67-5
Purity: 99.32% Supply Ability: 10g
Release date: 2025/04/27

Product Introduction

Bioactivity

NameTrichlormethiazide
DescriptionTrichlormethiazide (Naqua) is a short-acting, 3-dichloromethyl derivative of hydrochlorothiazide, belonging to the class of thiazide diuretics. Trichlormethiazide appears to block the active reabsorption of chloride and possibly sodium in the ascending loop of Henle, altering electrolyte transfer in the proximal tubule.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationDMSO : 50 mg/mL (131.35 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
KeywordsTrichlormethiazide | Na+/K+-ATPase | Inhibitor | inhibit | hypertension | diuretic | CarbonicAnhydrase | Carbonic anhydrase | Carbonic Anhydrase | antihypertensive | angiotensin | acute renal failures
Inhibitors RelatedBenzenesulfonamide | Cyclamic acid sodium | Sodium oleate | Hydrochlorothiazide | Orthanilamide | Tioxolone | trans-Aconitic acid | pNNP | Phlorizin | Chlorpropamide | Revaprazan hydrochloride | Oleic acid
Related Compound LibrariesBioactive Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | NO PAINS Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Metabolism Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$45.00/500mg
VIP3Y
TargetMol Chemicals Inc.
2025-04-30
$45.00/500mg
VIP1Y
TargetMol Chemicals Inc.
2025-04-29
$20.00/1kg
Shaanxi Franta Biotechnology Co., Ltd
2024-04-01
$20.00/1kg
Suzhou Sanyi Polymer Chemical Technology Co., Ltd.
2024-03-27
$40.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-09-18
$30.00/1kg
Anhui Ruihan Technology Co., Ltd
2023-09-08
$100.00/1bag
Hebei Fengqiang Trading Co., LTD
2023-09-05
$50.00/1kg
Henan Bao Enluo International TradeCo.,LTD
2023-07-20
$20.00/1kg
VIP3Y
Hebei Miaoyin Technology Co.,Ltd
2023-04-13
$5.00/1g
Hebei Endun Biological Technology Co. LTD
2023-03-15
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY